Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading 4.4% Higher – What’s Next?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) shares traded up 4.4% during mid-day trading on Friday . The company traded as high as $18.86 and last traded at $18.30. 6,240 shares were traded during mid-day trading, a decline of 77% from the average session volume of 26,930 shares. The stock had previously closed at $17.53.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. William Blair reiterated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th. UBS Group increased their target price on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Monday, January 27th.

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The firm has a fifty day simple moving average of $17.70.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.